Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline

Article Types

Countries / Regions

Search Results (3)

Search Parameters:
Authors = Masatake Tanaka ORCID = 0000-0001-7461-0678

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
7 pages, 603 KiB  
Article
The Efficacy of Tofogliflozin on Metabolic Dysfunction-Associated Fatty Liver Disease
by Takeshi Goya, Koji Imoto, Shigeki Tashiro, Tomomi Aoyagi, Motoi Takahashi, Miho Kurokawa, Hideo Suzuki, Masatake Tanaka, Masaki Kato, Motoyuki Kohjima and Yoshihiro Ogawa
Gastroenterol. Insights 2022, 13(1), 20-26; https://doi.org/10.3390/gastroent13010003 - 15 Jan 2022
Cited by 6 | Viewed by 3765
Abstract
The increasing number of patients with fatty liver disease is a major health problem. Fatty liver disease with metabolic dysfunction has been recognized as nonalcoholic fatty liver disease (NAFLD). Although there is no standard therapy for NAFLD, previous reports support the effect of [...] Read more.
The increasing number of patients with fatty liver disease is a major health problem. Fatty liver disease with metabolic dysfunction has been recognized as nonalcoholic fatty liver disease (NAFLD). Although there is no standard therapy for NAFLD, previous reports support the effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on NAFLD. Recently, fatty liver disease with metabolic dysfunction was proposed to be defined as a novel concept, “metabolic associated fatty liver disease (MAFLD)”, and it was proposed that new criteria for MAFLD diagnosis be established. To clarify the effect of SGLT2 inhibitors on MAFLD, we analyzed the efficacy of tofogliflozin in patients with MAFLD. We conducted a single-center, retrospective study to evaluate the efficacy of tofogliflozin in patients with MAFLD treated at Kyushu University Hospital between 2017 and 2019. Tofogliflozin was used to treat 18 patients with MAFLD. To determine the efficacy of tofogliflozin, we evaluated glucose metabolism, insulin resistance, liver injury, hepatic steatosis, and body composition three and six months after drug initiation. Although our study was a preliminary study because of some limitations (e.g., retrospective, observational, single-arm study, small sample size), we show that tofogliflozin could improve liver injury in patients with MAFLD by improving glucose metabolism and insulin resistance without causing muscle loss. Full article
(This article belongs to the Section Liver)
Show Figures

Figure 1

8 pages, 1938 KiB  
Article
The Combination of Nucleotide Analog Therapy and Steroid Pulse Therapy for Acute HBV Infection Effectively Promotes HBV Clearance
by Takeshi Goya, Tomoyuki Kurashige, Miho Kurokawa, Masatake Tanaka, Tomomi Aoyagi, Motoi Takahashi, Koji Imoto, Shigeki Tashiro, Hideo Suzuki, Masaki Kato, Motoyuki Kohjima and Yoshihiro Ogawa
Gastroenterol. Insights 2022, 13(1), 1-8; https://doi.org/10.3390/gastroent13010001 - 31 Dec 2021
Cited by 2 | Viewed by 3279
Abstract
Acute hepatitis B virus (HBV) infection occasionally progresses to acute liver failure, often with poor prognosis. The appropriate pharmacological approach is yet to be established. Although nucleotide analogs (NA) and corticosteroids are candidates for the treatment of acute HBV infection, their therapeutic effects, [...] Read more.
Acute hepatitis B virus (HBV) infection occasionally progresses to acute liver failure, often with poor prognosis. The appropriate pharmacological approach is yet to be established. Although nucleotide analogs (NA) and corticosteroids are candidates for the treatment of acute HBV infection, their therapeutic effects, especially their effect on HBV clearance, remain unclear. To clarify effects on the HBV clearance of combination therapy of NA and steroid pulse therapy (SPT) for acute HBV infection, we first analyze the effectiveness of this therapy in patients with HBV infection compared with NA monotherapy (NAM). Of the 57 consecutive patients with acute hepatitis B infection from May 2007 to December 2018, we have included 25 patients for this study, whom we followed up until HBV clearance. According to the administration of NA and SPT, we divided patients into two groups (NAM group and NA + SPT group) and compared their results. Of the 25 patients, 10 received NAM, whereas 15 received NA + SPT. There were no appreciable adverse effects related to SPT. The time required for the clearance of HBsAg (76 (43–116) days vs. 26 (14–51) days, p = 0.0418) and HBV-DNA (NAM group vs. NA + SPT group: 180 (83.5–220) vs. 69 (43–136) days, p = 0.0420) was significantly shorter in the NA + SPT group than in the NAM group. The hazard ratio of NA + SPT for the clearance of HBsAg and HBV-DNA were 0.45 (0.19–1.09) and 0.35 (0.14–0.89), respectively. In conclusion, we showed that NA + SPT promoted HBV elimination. These findings support the use of the NA + SPT combination for acute HBV infection without the concern of persistent HBV infection. Full article
(This article belongs to the Section Liver)
Show Figures

Figure 1

14 pages, 2493 KiB  
Article
Effects of Throughfall Exclusion on Photosynthetic Traits in Mature Japanese Cedar (Cryptomeria japonica (L. f.) D. Don.)
by Tanaka Kenzo, Yuta Inoue, Masatake G. Araki, Tatsuro Kawasaki, Satoshi Kitaoka, Tatsuya Tsurita, Tadashi Sakata and Satoshi Saito
Forests 2021, 12(8), 971; https://doi.org/10.3390/f12080971 - 22 Jul 2021
Cited by 9 | Viewed by 3115
Abstract
As climate change progresses, it is becoming more crucial to understand how timber species respond to increased drought frequency and severity. Photosynthetic traits in a 40-year-old clonal Japanese cedar (Cryptomeria japonica) plantation were assessed under artificial drought stress using a roof [...] Read more.
As climate change progresses, it is becoming more crucial to understand how timber species respond to increased drought frequency and severity. Photosynthetic traits in a 40-year-old clonal Japanese cedar (Cryptomeria japonica) plantation were assessed under artificial drought stress using a roof to exclude rainfall and a control with no exclusion. C. japonica is a commercial tree that is native to Japan and has high growth on mesic sites. The maximum carboxylation rate (Vcmax), maximum electron transfer rate (Jmax), and dark respiration rate (Rd) in current-year shoots in the upper canopy were determined from spring to autumn over two growing seasons. In addition, the photosynthetic rate at light saturation (Pmax), stomatal conductance (gs), and intrinsic water use efficiency (WUEi) were measured in the morning and afternoon during the same period. Leaf mass per unit area (LMA) and nitrogen concentration (N) were also measured. The values of Vcmax, Jmax, Rd, N, and LMA did not differ between the two plots. By contrast, significantly lower Pmax and gs and higher WUEi were found in the drought plot, and the reduction in Pmax was accompanied by low gs values. Midday depressions in Pmax and gs were more pronounced in the drought plot relative to the control and were related to higher WUEi. Under drought conditions, mature Japanese cedar experienced little change in photosynthetic capacity, foliar N, or LMA, but they did tend to close the stomata to regulate transpiration, thus avoiding drought-induced damage to the photosynthetic machinery and improving WUEi. Full article
(This article belongs to the Special Issue Ecophysiology of Forest Succession under Changing Environment)
Show Figures

Figure 1

Back to TopTop